Chugai Pharmaceutical Co., Ltd. (Japan) Standardizes on Medidata Rave Clinical Technology

NEW YORK & TOKYO--(BUSINESS WIRE)--Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, today announced that Chugai Pharmaceutical Co., Ltd., a member of the Roche Group and one of Japan’s leading pharmaceutical companies, has selected Medidata Rave® as the standard electronic data capture (EDC) and clinical data management (CDM) platform for its clinical trials. Chugai intends to use Medidata Rave to support all studies conducted during the multiyear contract term, from Phase I-IV.